Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria

BACKGROUND: The use of angiotensin-converting enzyme inhibitors (ACEI) has been associated with the development of bradykinin-mediated angioedema. With ever-widening indications for ACEI in diseases including hypertension, congestive heart failure and diabetic nephropathy, a concomitant increase in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Health Serv Res
Autores principales: Bonner, Nicola, Panter, Charlotte, Kimura, Alan, Sinert, Rich, Moellman, Joseph, Bernstein, Jonathan A.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5440910/
https://ncbi.nlm.nih.gov/pubmed/28532495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2274-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares